News
15 February 2022
EU
CARE, - Medicines

Following an annual assessment, the European Medicines Agency (EMA), the EU regulatory agency responsible for the evaluation of medicinal products, has confirmed the continued compliance of EFA with the criteria required to be an “eligible organisation” to EMA.

As an eligible organization, EFA continues to be a recognised and trusted organisation by the EMA, and that we will continue representing allergy, asthma and COPD patients in the EMA Patients' and Consumers' Working Party (PCWP).

EFA has been an EMA eligible organisation since 2013 and is represented by former Vice-President Erna Botjes and Deputy Director Isabel Proaño as her alternate.

Don’t hesitate to take a look at the many other official partnerships that EFA holds with regulatory bodies and institutions.